What is a ‘natural’ dye, anyway?
60%STAT News•2/6/2026
← All Domains
Biotech & Health
Pharmaceuticals, healthcare policy, pandemics, and medical research
156 articles
6 sources
Sources (6)
STAT News
rss65% reliability
BioPharma Dive
rss65% reliability
Endpoints News
rss65% reliability
FierceBiotech
rss65% reliability
BioPharma Dive
rss80% reliability
Endpoints News
rss80% reliability
Recent Intelligence
STAT+: IPOs, GLP-1s, and challenges with a gene therapy
50%STAT News•2/6/2026
GSK’s new CEO eyes more dealmaking, intense pipeline inspection
55%Endpoints News•2/4/2026
Rare pediatric PRV program reauthorized until 2029 via government funding law
55%Endpoints News•2/4/2026
AbbVie says immunology blockbusters will be 'main drivers' of growth post-Humira
55%Endpoints News•2/4/2026
FTC settles insulin lawsuit with Express Scripts
55%Endpoints News•2/4/2026
Flagship's Generate:Biomedicines files for IPO, pitching AI-driven drugs
50%Endpoints News•2/5/2026
Angitia gets $130M Series D for pipeline of musculoskeletal drugs
55%Endpoints News•2/5/2026
Eisai gains Henlius therapy; LB Pharma snags $100M in funding
60%Endpoints News•2/5/2026
Eikon IPO analysis: Big biotech names, big valuation cut
55%Endpoints News•2/5/2026
Telehealth provider Hims goes after Novo's weight loss pill with compounded version
55%Endpoints News•2/5/2026
Thermo Fisher, Charles River workforce cuts; WuXi signs contract with Vertex
55%Endpoints News•2/5/2026
GLP-1s and the Super Bowl
50%Endpoints News•2/5/2026
Bristol Myers draws pipeline excitement as several data readouts near
55%Endpoints News•2/5/2026
#ISC26: Bayer’s asundexian reduced ischemic strokes by 26% in Phase 3 trial
55%Endpoints News•2/5/2026
Veradermics CEO has a great hair day with 122% pop in IPO
55%Endpoints News•2/5/2026
White House launches TrumpRx
70%Endpoints News•2/5/2026
Novo's threat to sue Hims over Wegovy pill faces legal hurdle
50%Endpoints News•2/5/2026
FDA chief Makary takes aim at Hims' compounded Wegovy pill plans
55%Endpoints News•2/5/2026
Illumina bets on healthcare after Trump administration's NIH funding disruptions
55%Endpoints News•2/6/2026